Candriam S.C.A. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,932,316
+23.3%
893,763
+2.3%
0.28%
+21.1%
Q2 2023$31,569,057
+20.7%
873,763
+14.3%
0.23%
+26.0%
Q1 2023$26,154,414
-24.8%
764,265
-0.4%
0.18%
-23.0%
Q4 2022$34,778,146
-24.8%
767,596
+15.9%
0.24%
-27.9%
Q3 2022$46,271,000
+16.0%
662,501
+11.5%
0.33%
-0.9%
Q2 2022$39,893,000
-4.3%
594,284
+17.3%
0.33%
+15.8%
Q1 2022$41,665,000
-42.3%
506,773
+2.9%
0.28%
-38.4%
Q4 2021$72,242,000
+6.6%
492,483
+28.5%
0.46%0.0%
Q3 2021$67,793,000
+21.4%
383,219
+10.9%
0.46%
+20.7%
Q2 2021$55,824,000
+39.9%
345,596
+82.8%
0.38%
+15.1%
Q1 2021$39,896,000
-3.9%
189,100
+0.0%
0.33%
+0.9%
Q4 2020$41,536,000
+87.9%
189,098
+42.0%
0.33%
+58.2%
Q3 2020$22,107,000
+75.9%
133,137
+21.0%
0.21%
+56.4%
Q2 2020$12,566,000
+0.4%
110,061
+10.8%
0.13%
-4.3%
Q1 2020$12,511,000
-2.3%
99,328
+0.0%
0.14%
+1.5%
Q4 2019$12,799,000
+34.3%
99,323
-18.8%
0.14%
+8.7%
Q3 2019$9,528,000
-40.8%
122,300
-22.1%
0.13%
-37.3%
Q2 2019$16,100,000
+94.4%
157,000
+38.9%
0.20%
+89.6%
Q1 2019$8,283,000
-7.5%
113,000
-46.4%
0.11%
-23.2%
Q4 2018$8,950,000
-1.0%
211,000
+9.9%
0.14%
+15.0%
Q3 2018$9,043,000
+97.9%
192,000
+107.1%
0.12%
+66.7%
Q2 2018$4,570,000
+1096.3%
92,700
+32.4%
0.07%
+620.0%
Q2 2016$382,000
-82.7%
70,000
-32.7%
0.01%
-81.8%
Q1 2016$2,214,000
-39.1%
104,000
-9.6%
0.06%
-43.3%
Q4 2015$3,634,000
-1.3%
115,000
+7.5%
0.10%
+7.8%
Q3 2015$3,683,000
+6.4%
107,000
-2.7%
0.09%
+25.0%
Q2 2015$3,462,000
+3.6%
110,000
-3.5%
0.07%
+7.5%
Q1 2015$3,343,000
+157.9%
114,000
+62.9%
0.07%
+148.1%
Q4 2014$1,296,00070,0000.03%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders